By Davit Kerakossian
Every day Wall Street Research analysts start a new coverage of stocks in the sectors they follow and make ratings, such as buy/hold/sell, target price setting, earnings release and other financial estimates. Here are 5 new covering stocks that caught our eye today:
RBC Capital commenced coverage on nike (NYSE: With an outperform rating and a $125.00 target price, China’s recovery is seen as a catalyst for improving sentiment, showing early signs of promise. According to the brokerage, the company has demonstrated its ability to stay one step ahead, as business shifts digital, and apps restart in China , ERP upgrade, and recent RTFKT acquisition proof points.
Goldman Sachs started coverage of Revance Therapeutic (NASDAQ:) with a buy rating and a target price of $33.00.
Baird kicked off the coverage on Netstreit Corp (NYSE:) with an Outperform rating and a price target of $23.00, noting that it believes the combination of a high-quality portfolio, consistent acquisition activity and a reasonable valuation should outperform.
Raymond James started Prudential Financial (NYSE:) coverage with a strong buy rating and $115.00 target price.
Cowen started the coverage on 23AndMe Holding Co (NASDAQ 🙂 with an outperform rating and a price target of $6.00 given divergent assets and a large cash rung.